Key clinical point:
Major finding: Antenatal betamethasone treatment was linked to $4,681 per mother-infant pair, compared with $5,379 without corticosteroids (P = .02 for $698 difference).
Study details: The findings are based on a secondary analysis of a randomized clinical trial from October 2010 to February 2015 involving 2,821 mothers at high risk for preterm birth, and their infants.
Disclosures: The National Institutes of Health funded the research. Dr. Gyamfi-Bannerman received a grant from AMAG pharmaceuticals during the conduct of the study.
Gyamfi-Bannerman C. JAMA Pediatr. 2019 Mar 11.
This Week's Must Reads
Term Cesarean Delivery & Subsequent Preterm Delivery, Am J Obstet Gynecol; ePub 2019 Feb 22; Vahanian, et al
Bleeding and Spotting with the LNG 13.5 mg IUS, Contraception; ePub 2019 Mar 1; Shimoni, et al
Apical Suspension at the Time of Vaginal Hysterectomy, Female Pelvic Med Reconstr Surg; ePub 2019 Feb 21; Sheyn, et al